Report - ANEXO I RESUMEN DE LAS CARACTERÍSTICAS …ec.europa.eu/health/documents/community-register/2007/... · propanolol y selegilina. No se espera que los agonistas y antagonistas dopaminérgicos

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form